ReShape Lifesciences Soars 34.02% on Strategic Partnership

On June 12, 2025, ReShape Lifesciences surged 34.02% in pre-market trading, marking a significant rise in its stock price.

ReShape Lifesciences has recently announced a strategic partnership with Recon Supply, which will serve as the exclusive distributor of ReShape's innovative portfolio, including the STIMEL-03 neuromuscular rehabilitation device. This collaboration aims to expand ReShape's market reach, particularly within the VA and DoD markets, by leveraging Recon Supply's extensive distribution network.

This partnership is expected to enhance ReShape's market presence and drive growth by making its cutting-edge products more accessible to a broader range of customers. The distribution agreement underscores ReShape's commitment to advancing neuromuscular rehabilitation technologies and improving patient outcomes.